Strategic Partnership Boosts Drug Development Solutions
ArisGlobal, a leading technology company in the life sciences industry, has strengthened its strategic partnership with Sitero LLC, an innovative provider of clinical trial solutions. This collaboration enhances ArisGlobal's LifeSphere R&D technology suite by incorporating Sitero’s cutting-edge eClinical technology platform, which features a range of essential tools for conducting clinical trials.
The improvements resulting from this partnership aim to deliver a seamless and efficient experience throughout the entire drug development process. By focusing on end-to-end connectivity and ensuring smooth interoperability among Clinical, Safety, Regulatory, Medical Affairs, and Quality platforms, ArisGlobal and Sitero empower their clients to benefit from a modernized R&D IT ecosystem.
Key Advantages of the Enhanced Partnership
This collaboration presents significant benefits for global life sciences customers:
Streamlined Data Workflows
The integration promotes effective workflows by automating secure data sharing across various platforms, addressing cost challenges faced by organizations in the life sciences sector.
Improved Data Integrity and Compliance
With enhanced accuracy and reliability, the new framework is set to elevate quality at every stage of eClinical trials while ensuring compliance through thorough data verification processes.
Automation of Processes
Advanced automation features will reduce clinical trial errors, facilitating smoother data reconciliation, touchless archiving, and accurate source data verification.
Simplifying IT Infrastructure
The combined technology solutions enable organizations to function under a unified agreement across different facets of drug development. This approach reduces operational complexity and optimizes overall costs, leading to a more streamlined management of technology.
Executive Insights on the Partnership
Aman Wasan, CEO of ArisGlobal, highlighted the company's dedication to enhancing end-user benefits and optimizing processes. He stated that this integration not only boosts operational efficiency but also provides significant ROI for their partners. He mentioned that LifeSphere is consistently investing in robust safety and regulatory platforms, bolstered by next-generation cognitive computing technologies that are transforming the R&D landscape.
Moreover, Sankesh Abbhi, CEO of Sitero, shared his thoughts on the company’s mission to accelerate the delivery of treatments through technology-driven services. He emphasized that the expanded partnership with ArisGlobal allows them to provide substantial value to pharmaceutical companies through a fully integrated solution.
About the Companies
About ArisGlobal
ArisGlobal is at the forefront of life sciences technology, delivering innovative solutions that help companies efficiently develop breakthroughs and launch new products. With operations in various regions worldwide, ArisGlobal is committed to transforming the life sciences sector through cutting-edge technology.
About Sitero
Sitero is focused on assisting life sciences and research organizations in accelerating clinical trials while ensuring safety and compliance through advanced technologies. The company combines extensive expertise with a modern approach to provide drug developers with innovative solutions.
Frequently Asked Questions
What is the significance of the partnership between ArisGlobal and Sitero?
This partnership enhances the connectivity and data flow throughout the drug development process, making clinical trials more efficient and effective.
How does this collaboration benefit drug developers?
It streamlines workflows, improves data integrity, and simplifies IT infrastructure, ultimately leading to lower costs and higher success rates in trials.
What technologies are integrated into the partnership?
The collaboration includes tools for electronic data capture, remote trial management, eConsent, and more, creating a comprehensive platform for clinical trials.
Who are the leaders of these companies?
Aman Wasan is the CEO of ArisGlobal, while Sankesh Abbhi serves as the CEO of Sitero, both of whom play crucial roles in driving this strategic partnership.
Where can I find more information about ArisGlobal and Sitero?
Additional information can be found on their respective websites, where they provide updates on their services and partnerships within the life sciences sector.
